Jorge Alvar mainly investigates Leishmaniasis, Immunology, Visceral leishmaniasis, Virology and Epidemiology. His study of Leishmania infantum is a part of Leishmaniasis. His biological study spans a wide range of topics, including Disease and Intensive care medicine.
His research in Visceral leishmaniasis intersects with topics in Global health, Internal medicine, Incidence and Pharmacology. The Virology study combines topics in areas such as Genotype, Apicomplexa and Polymerase chain reaction. His Epidemiology study frequently draws connections to other fields, such as Acquired immunodeficiency syndrome.
His scientific interests lie mostly in Leishmaniasis, Visceral leishmaniasis, Immunology, Virology and Leishmania infantum. His Leishmaniasis study combines topics from a wide range of disciplines, such as Epidemiology, Incidence, Disease and Leishmania. His Visceral leishmaniasis study incorporates themes from Veterinary medicine, Internal medicine, Pharmacotherapy and Intensive care medicine.
His Acquired immunodeficiency syndrome research extends to Immunology, which is thematically connected. His study in the field of Viral disease and Infectivity also crosses realms of Xenodiagnosis. The concepts of his Leishmania infantum study are interwoven with issues in Phlebotomus, Kinetoplastida, Psychodidae and Asymptomatic.
Jorge Alvar focuses on Visceral leishmaniasis, Leishmaniasis, Internal medicine, Miltefosine and Incidence. The study incorporates disciplines such as Veterinary medicine, Asymptomatic and Intensive care medicine in addition to Visceral leishmaniasis. Leishmaniasis is a subfield of Immunology that he investigates.
His work on Pharmacotherapy, Prospective cohort study, Disease burden and Survival analysis is typically connected to Major depressive disorder as part of general Internal medicine study, connecting several disciplines of science. His research integrates issues of Regimen, Adverse effect and Combination therapy in his study of Miltefosine. His Incidence research incorporates elements of Global health, Epidemiology, Neglected tropical diseases and Cutaneous leishmaniasis.
Visceral leishmaniasis, Leishmaniasis, Internal medicine, Miltefosine and Paromomycin are his primary areas of study. His study in Visceral leishmaniasis is interdisciplinary in nature, drawing from both Leishmania, Pharmacotherapy and Asymptomatic. His Leishmaniasis study results in a more complete grasp of Immunology.
His Internal medicine study combines topics in areas such as Global health and Cutaneous leishmaniasis. His Miltefosine research integrates issues from Regimen and Intensive care medicine. As part of one scientific family, Jorge Alvar deals mainly with the area of Post-kala-azar dermal leishmaniasis, narrowing it down to issues related to the Phlebotomus, and often Parasite load, Dermatology and Incidence.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
Leishmaniasis Worldwide and Global Estimates of Its Incidence
Jorge Alvar;Iván D. Vélez;Iván D. Vélez;Caryn Bern;Mercé Herrero.
PLOS ONE (2012)
Visceral leishmaniasis: what are the needs for diagnosis, treatment and control?
François Chappuis;François Chappuis;Shyam Sundar;Asrat Hailu;Hashim Ghalib.
Nature Reviews Microbiology (2007)
The Relationship between Leishmaniasis and AIDS: the Second 10 Years
Jorge Alvar;Pilar Aparicio;Abraham Aseffa;Margriet Den Boer.
Clinical Microbiology Reviews (2008)
Leishmania and human immunodeficiency virus coinfection: the first 10 years.
J Alvar;C Cañavate;B Gutiérrez-Solar;M Jiménez.
Clinical Microbiology Reviews (1997)
Leishmaniasis and poverty.
Jorge Alvar;Sergio Yactayo;Caryn Bern.
Trends in Parasitology (2006)
Canine leishmaniasis: epidemiological risk and the experimental model
Javier Moreno;Jorge Alvar.
Trends in Parasitology (2002)
Leishmania/HIV co-infections: epidemiology in Europe.
P. Desjeux;J. Alvar.
Annals of Tropical Medicine and Parasitology (2003)
Complexities of assessing the disease burden attributable to leishmaniasis.
Caryn Bern;James H. Maguire;Jorge Alvar.
PLOS Neglected Tropical Diseases (2008)
Infectivity of dogs naturally infected with Leishmania infantum to colonized Phlebotomus perniciosus
R. Molina;C. Amela;J. Nieto;M. San-Andrés.
Transactions of The Royal Society of Tropical Medicine and Hygiene (1994)
Liposomal Amphotericin B for the Treatment of Visceral Leishmaniasis
Caryn Bern;Jill Adler-Moore;Juan Berenguer;Marleen Boelaert.
Clinical Infectious Diseases (2006)
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below: